Shares fall 5% after Kangmei says $4.4bn cash overstatement linked to faked paperwork
Related Posts
Suning Open Platform Commodity Trade Scale Up 56.83% In First Three Quarters of 2020
China’s 14th Five-Year Plan Aims To Increase R&D Spending, Tax Credit To Spur Basic Research
Shenzhen Idea International Completes $35M Series A Round
Leland Miller: China's Slowdown Is Actually A Bullish Signal
Youths should balance hard work with healthy diet, lifestyle: Doctors- Biden traveling to Vietnam following G-20 summit next month
Xi pledges $60bn in support to Africa
Cathay Pacific/Hong Kong protests: been there, but no T-shirt
China's Private Equity Records First Rebound In Exits After Three Down Years
Kaiyuan Securities assigns a buy rating to Shandong Pharmaceutical Glass: The pharmaceutical glass industry has a good opportunity to upgrade, and industry leaders continue to benefit